Abstract:Abstract Introduction Hematopoietic stem cells (HSCs) sustain lifelong blood production and can be used in allogenic stem cell transplantation for treatment of hematological malignancies, yet the mechanisms of their DNA damage response (DDR) remain largely unexplored. Genotoxic damage can be induced by chemotherapeutical agents (eg, etoposide, a topoisomerase II inhibitor) or by methylating agents (eg, nitrosamines). Related double strand breaks (DSBs) at the level of immature cells are thus presumed to trigger leukemia. Objective Human quiescent and cycling HSCs were reported to exhibit distinct responses to genotoxic stress upon in vitro exposure to sublethal doses of etoposide or N-nitroso-N-methylurea (MNU). In this context, we aim to identify and compare the mechanisms involved in the determination of HSC stem and progenitor cell fate upon DNA damage to gain more insights into cytotoxic anticancer drug- and contaminant-related hematological toxicity. Methods Quiescent human HSCs (CD34+) were isolated from umbilical cord blood, sorted and directly exposed to etoposide or MNU. Besides, CD34+ were expanded in-vitro in medium containing broad acting cytokines for 5 days prior genotoxic exposure. Sublethal doses were assessed by Alamar Blue assay. Propidium iodide staining and colony-forming unit assay (CFU) were used for cell cycle analysis and tracking of cell functionality. Results In vitro inhibitory concentrations were identified for human HSCs treated with etoposide (IC50 = 5 μM) and MNU (IC50 = 1 mM). Treatment of quiescent HSCs with lower genotoxin concentrations induces a cell cycle arrest in the G0/G1-phase, whereas higher concentrations activate apoptosis-related genes and completely abrogate further differentiation into colony-forming progenitors. In contrast, cycling HSCs exhibit an impaired proliferation, upregulation of autophagy-related genes, reduced proportions of viable CD34+ cells, and similar effects regarding differentiation capacity into colony-forming progenitors. However, cells exposed to lower genotoxin doses exhibit a higher regeneration capacity 3 days upon treatment. Discussion These results confirm that the DDR following DSB-induction differs between quiescent and cycling HSCs. Quiescent HSCs exhibit a stronger DDR, probably related to their longer lifespan. To avoid malignant transformation, it is necessary to preclude damage accumulation through cell cycle withdrawal and apoptosis. In contrast, more committed cells rather inline toward damage repair and restoration through activation of, for example, non-homologous end joining or mismatch repair genes.

Mitochondrial Dysfunction and Oxidative Stress in Bone Marrow Stromal Cells Induced by Daunorubicin Leads to DNA Damage in Hematopoietic Cells.

Leukemic Bone Marrow Stromal Cells Inhibit Apoptosis of Leukemic Cell Line Jurkat Cells Induced by DNR in Vitro

Disruption of Dntp Homeostasis by Ribonucleotide Reductase Hyperactivation Overcomes AML Differentiation Blockade

Daunorubicin-loaded magnetic nanoparticles of Fe3O4 overcome multidrug resistance and induce apoptosis of K562-n/VCR cells in vivo.

Abstract 1 Distinctive and Differentiation-State Dependent DNA Damage Response of Hematopoietic Stem Cells to Genotoxic Noxae

Effects of 5-Bromotetrandrine and Daunorubicin on the Expression of Survivin in K562/AO2 Cells

Autophagy Inhibition Enhances Daunorubicin-Induced Apoptosis In K562 Cells

Doxorubicin Caused Apoptosis of Mesenchymal Stem Cells Via P38, JNK and P53 Pathway.

Uncoupling DNA Damage from Chromatin Damage to Detoxify Doxorubicin.

Hematopoietic Stem Cell Senescence and Cancer Therapy-Induced Long-Term Bone Marrow Injury.

Early Transcriptional Changes in Cardiac Mitochondria During Chronic Doxorubicin Exposure and Mitigation by Dexrazoxane in Mice.

DNA Damage Response-Initiated Cytokine Secretion in Bone Marrow Stromal Cells Promotes Chemoresistance of Myeloma Cells.

Effects of 5-bromotetrandrine and daunorubicin on apoptosis and expression of survivin in K562/A02 cells]

CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells

Chemotherapeutic Drugs Induce Oxidative Stress Associated with DNA Repair and Metabolism Modulation.

Effects of bone marrow stromal cells and umbilical cord blood-derived stromal cells on daunorubicin-resistant residual Jurkat cells.

Bone marrow mesenchymal stem cells alleviate the daunorubicin-induced subacute myocardial injury in rats through inhibiting infiltration of T lymphocytes and antigen-presenting cells

Role of ErbB2 Mrna Expression and Cell Apoptosis in Development of Cardiomyopathy Caused by Daunorubicin in Rats

Doxorubicin In Vivo Rapidly Alters Expression And Translation Of Myocardial Electron Transport Chain Genes, Leads To Atp Loss And Caspase 3 Activation

Apoptotic Mechanism of Human Leukemia K562/A02 Cells Induced by Magnetic Iron Oxide Nanoparticles Co-Loaded with Daunorubicin and 5-Bromotetrandrin

Disrupted Mitochondrial Homeostasis Coupled with Mitotic Arrest Generates Antineoplastic Oxidative Stress.